Combination of Tarlatamab and Temozolomide in Patients With Central Nervous System Tumors
Clinical trial NCT07243470 · RECRUITING
Trial details
- NCT number
- NCT07243470
- Sponsor
- Centre Leon Berard
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-11-04
- Primary completion
- 2029-10-01
- Enrollment
- 70
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.